Literature DB >> 11606366

A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.

X Zhao1, J Li, Y He, F Lan, L Fu, J Guo, R Zhao, Y Ye, M He, W Chong, J Chen, L Zhang, N Yang, B Xu, M Wu, D Wan, J Gu.   

Abstract

Previous studies have shown that there is a high frequency of loss of heterozygosity (LOH) on chromosome 17p13.3 in hepatocellular carcinoma [HCC (M. Fujimori et al., Cancer Res., 51: 89-93, 1991; H. Nagai et al., Oncogene, 14: 2927-2933, 1997; V. Boige et al., Cancer Res., 57: 1986-1990, 1997; Z. Piao et al., Int. J. Cancer, 75: 29-33, 1998; and B. Charroux et al., J. Cell Biol., 148: 1177-1186, 2000)]. The minimum region of LOH on chromosome 17p13.3 in HCC has been defined within the region between D17S643 and D17S1574. Moreover, D17S926 in the minimum region of LOH has the highest frequency of LOH, and its sequencing analysis has been accomplished. In this region, 6 of 13 novel genes have been characterized (X. Zhao, D. Wan, M. He, Yu. Ye, Yi. He, L. Han, M. Guo, Y. Huang, W. Qin, M-W. Wang, W. Chong, J. Chen, L. Zhang, N. Yang, B. Xu, M. Wu, L. Zuo, and J. Gu. A high frequency LOH region on chromosome 17p13.3 in human HCC with densely clustered genes identified, submitted for publication). Here we describe the cloning and characterization of one of these novel genes, designated HCC suppressor 1 (HCCS1), located at this region. HCCS1 had 18 exons, and its full-length cDNA was 2.0 kb. The protein expression product of HCCS1 was located in mitochondria. HCCS1 had a high frequency of mutations in HCC samples, whereas no alteration has been found in matched noncancerous liver tissues. Immunohistochemistry revealed a significantly higher expression of HCCS1 in the noncancerous liver tissues (33 of 35 samples) than in the HCC samples (2 of 35 samples). Transfection of HCCS1 cDNA into the HCC cell line remarkably reduced the efficiency of its colony formation and inhibited tumor growth in nude mice. Taken together, these findings strongly suggest a potential role of HCCS1 as a HCC putative suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606366

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Large-scale cDNA transfection screening for genes related to cancer development and progression.

Authors:  Dafang Wan; Yi Gong; Wenxin Qin; Pingping Zhang; Jinjun Li; Lin Wei; Xiaomei Zhou; Hongnian Li; Xiaokun Qiu; Fei Zhong; Liping He; Jian Yu; Genfu Yao; Huiqiu Jiang; Lianfang Qian; Ye Yu; Huiqun Shu; Xianlian Chen; Huili Xu; Minglei Guo; Zhimei Pan; Yan Chen; Chao Ge; Shengli Yang; Jianren Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

Review 2.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  VPS52 induces apoptosis via cathepsin D in gastric cancer.

Authors:  Jian Zhang; Ying Lin; Xichun Hu; Zheng Wu; Weijian Guo
Journal:  J Mol Med (Berl)       Date:  2017-08-08       Impact factor: 4.599

4.  Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.

Authors:  Shu-Hui Zhang; Wen-Ming Cong; Zhi-Hong Xian; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 5.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

6.  Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities.

Authors:  Shu-Hui Zhang; Wen-Ming Cong; Jing-Quan Shi; Hong Wei
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 7.  Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

Authors:  De-Leung Gu; Yen-Hsieh Chen; Jou-Ho Shih; Chi-Hung Lin; Yuh-Shan Jou; Chian-Feng Chen
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

8.  HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.

Authors:  Hai-Neng Xu; Wei-Dan Huang; Ying Cai; Miao Ding; Jin-Fa Gu; Na Wei; Lan-Ying Sun; Xin Cao; Hua-Guang Li; Kang-Jian Zhang; Xin-Ran Liu; Xin-Yuan Liu
Journal:  Mol Cancer       Date:  2011-11-01       Impact factor: 27.401

9.  Expression and clinical significance of HCCS1 in non-small cell lung cancer.

Authors:  Shen Xiao-Yong; Lin Zhi-Feng; Lu Fan-Zhen; Ruan Zhen; Zhen Jian; Huang Hai-Long; Ju Chao-Qiang
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

Review 10.  The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.

Authors:  Ming Liu; Lingxi Jiang; Xin-Yuan Guan
Journal:  Protein Cell       Date:  2014-06-11       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.